Clinical TrialsSearch results
Number of results: 821
Recruiting
- ONO-1110-01:Phase 1 study of the safety, tolerability, pharmacokinetics of ONO-1110 in healthy Japanese adult male subjects
- Healthy volunteers(The planned indication has not been determined.)
- Masahiro Osawa
- 2023-01-31
Recruiting
- ONO-1110-03 : A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-1110 in Healthy Japanese Adult Male Subjects
- Healthy volunteers
- Osawa Masahiro
- 2024-05-21
Recruiting
- ONO-4685-04: ONO-4685 Phase 1 study
- Auto immune disease
- Masahiro Osawa
- 2022-12-23
Recruiting
- Phase 3 Study to Evaluate Mezigdomide (CC-92480/BMS-986348) in Combination
with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma:
SUCCESSOR-2
- Multiple Myeloma
- Engelhardt Brian
- 2023-11-25
Recruiting
- Phase I clinical trial of GAIA-102 for refractory/relapse neuroblastomas and other malignant pediatric solid tumors
- refractory/relapse neuroblastoma and other pediatric solid tumors
- Kawakubo Naonori
- 2022-09-23
Recruiting
- Phase I study evaluating tolerability, safety, pharmacokinetics, and efficacy of combined ONO-4059 and R-MPV therapy for PCNSL
- Primary central nervous system lymphoma
- Osawa Masahiro
- 2024-03-14
Recruiting
- Phase I Study of AK1910 in Healthy Japanese Subjects, Healthy Caucasian Subjects, Patients with Systemic Lupus Erythematosus
(Single Dose and Multiple Dose Study)
- Systemic Lupus Erythematosus
- Sato Kumiko
- 2023-11-07
Recruiting
- Phase I study using BK-UM against HB-EGF for patients with advanced or recurrent ovarian cancer
- Patients with recurrent ovarian cancer
- Fukuoka University Hospital
- 2008-01-30
Recruiting
- Phase II Study of Brigatinib for ALK-positive advanced non-small cell lung cancer with brain metastases
- ALK-positive advanced non-small cell lung cancer with brain metastases
- Naoki Katsuhiko
- 2023-06-20
Recruiting
- Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.
- colorectal cancer
- Translational Research Informatics Center(TRI)
- 2009-08-07